Medicare Coverage Of Reveal And Shield's FDA Approval Will Expand Market Reach

Shared on01 May 25
Fair value Increased 2.22%

Shared on24 Apr 25
Fair value Decreased 0.85%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 4.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 5.20%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.